With the Accelerated Access Review currently looking at how to speed up the availability of innovative medical technologies, there is a real and heightened focus from government and NHS England on how medical devices and diagnostics can play a more significant role in transforming healthcare delivery. Earlier this year, members of the Royal College of Pathologists (RCPath), the Association for Clinical Biochemistry and Laboratory Medicine (ACB) and the Institute of Biomedical Science (IBMS) took part in a workshop at the National Institute for Health and Care Excellence (NICE) exploring the potential for laboratory medicine professionals and the NICE Diagnostics Assessment Programme (DAP) working collaboratively in identifying diagnostic tests and technologies which could positively impact patient care and healthcare delivery.
展开▼
机译：随着《加速访问评论》目前正在研究如何加快创新医疗技术的可用性，英国政府和英国国家医疗服务体系（NHS）越来越重视将医疗设备和诊断方法如何在转变医疗保健服务方面发挥更重要的作用。今年早些时候，皇家病理学家学院（RCPath），临床生物化学和检验医学协会（ACB）和生物医学科学研究所（IBMS）的成员参加了美国国立卫生与护理卓越学院（National Institute for Health and Care Excellence）的研讨会。 NICE）探索了实验室医学专业人士和NICE诊断评估计划（DAP）共同合作确定可对患者护理和医疗服务产生积极影响的诊断测试和技术的潜力。
展开▼
